USPTO serial 98755109
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
CAMBRIDGE, MA, US
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
SUDIP K. MITRA
SUDIP K. MITRA VEDDER PRICE P.C.222 NORTH LASALLE STREETSUITE 2400CHICAGO, IL 60601| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Biological research and analysis; Medical research services; Scientific research, namely scientific research relating to genetic alterations; Research in the field of genetic diseases; Consulting services in the field of genetic science; Genetic sequencing services for scientific purposes; Providing medical research information in the field of genetics; Software as a service (SAAS) services featuring software used for the analysis of genomes, molecular diagnostic tests to predict treatment response and improve diagnostics in the medical, scientific and biological fields; Interactive web-based communication platform as a service featuring computer software platforms for medical and biological data sharing for disease, treatment, trial, outcome and molecular diagnostic test results for decision support; Providing medical and scientific research information in the fields of pharmaceuticals and genetics | ACTIVE | — |
| 044 | Genetic testing for medical purposes; Genetic testing for cancer risk for medical purposes; Genetic testing for medical purposes for detecting genetic predispositions; Genetic counseling; Medical counseling for the medical treatment of genetic predispositions; Providing information about genetic counseling; Health counseling; Medical clinic services; Medical services; Pharmaceutical advice; Telemedicine services; Health care services, namely, personalized end-to-end precision oncology therapy services, clinical decision support services in the nature of precision oncology decision-support reports based on tumor sequencing data and support services for healthcare professionals and patients in the nature of enabling evidence-based treatment decisions for healthcare professionals and patients via secure online platform and electronic delivery of clinical reports; Consulting services in the field of health care to assist with biomedical and clinical decisions; Medical diagnostic testing, monitoring and reporting services in the field of personalized medicine; Genetic sequencing for medical purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 8, 2026 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jun 8, 2026 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jun 8, 2026 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Jun 5, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 5, 2026 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jun 5, 2026 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jun 5, 2026 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Mar 5, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 5, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Dec 5, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 5, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 5, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 3, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 3, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 3, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 3, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 20, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 20, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 20, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 20, 2025 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Nov 20, 2025 | PETG | PETITION TO REVIVE-GRANTED | — |
| Nov 20, 2025 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Oct 6, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 6, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 20, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jun 20, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Mar 20, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 17, 2024 | NWAP | NEW APPLICATION ENTERED | — |